chrX-153982528-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003492.3(TMEM187):c.466G>A(p.Ala156Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,205,606 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM187 | NM_003492.3 | c.466G>A | p.Ala156Thr | missense_variant | 2/2 | ENST00000369982.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM187 | ENST00000369982.5 | c.466G>A | p.Ala156Thr | missense_variant | 2/2 | 1 | NM_003492.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000291 AC: 33AN: 113365Hom.: 0 Cov.: 25 AF XY: 0.000338 AC XY: 12AN XY: 35509
GnomAD3 exomes AF: 0.000126 AC: 22AN: 173942Hom.: 0 AF XY: 0.000115 AC XY: 7AN XY: 60976
GnomAD4 exome AF: 0.0000320 AC: 35AN: 1092241Hom.: 0 Cov.: 33 AF XY: 0.0000222 AC XY: 8AN XY: 360305
GnomAD4 genome AF: 0.000291 AC: 33AN: 113365Hom.: 0 Cov.: 25 AF XY: 0.000338 AC XY: 12AN XY: 35509
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.466G>A (p.A156T) alteration is located in exon 2 (coding exon 1) of the TMEM187 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the alanine (A) at amino acid position 156 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 13, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at